Connor Johnson a medical oncologist specializing in the care of patients with lymphoma and those receiving cellular therapies. His research career is focused on developing interventions and therapies to improve the quality-of-life and care delivery for patients with hematologic malignancies, with a particular focus on those with lymphoma and those receiving cellular therapies. After completing his training in internal medicine at MGH and Hematology/Oncology at the Dana-Farber Cancer Institute, he joined the faculty at MGH and HMS in July 2021, where he currently serves on the cellular therapy steering committee at MGH. He is an alumnus of the Lymphoma Research Foundation Scientific Mentoring Program and the recipient of American Society of Clinical Oncology and National Cancer Institute K08 Career Development Awards.